CEPI
@cepi.net
Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission
New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
October 22, 2025 at 10:33 AM
New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.
Last month, Health Emergencies Response Canada (HERC) and CEPI co-chaired a roundtable in Ottawa with organisations funding and delivering R&D for diagnostics, vaccines and therapeutics for epidemic and pandemic threats.
October 21, 2025 at 3:38 PM
Last month, Health Emergencies Response Canada (HERC) and CEPI co-chaired a roundtable in Ottawa with organisations funding and delivering R&D for diagnostics, vaccines and therapeutics for epidemic and pandemic threats.
Following the recent framework agreement with Fondation Mérieux, CEPI is also partnering with the @ukhsa.bsky.social to support biosecurity capacity strengthening with national public health institutions and universities involved in epidemic preparedness and infectious disease research across DRC.
October 17, 2025 at 2:00 PM
Following the recent framework agreement with Fondation Mérieux, CEPI is also partnering with the @ukhsa.bsky.social to support biosecurity capacity strengthening with national public health institutions and universities involved in epidemic preparedness and infectious disease research across DRC.
New CEPI-funded project will partner with Austria’s GENSPEED Biotech to repurpose its GENSPEED R2 device to create a fast, fully automated quality control test for detecting residual HEK293 host cell proteins, a critical step in ensuring vaccine safety and consistency.
October 17, 2025 at 10:20 AM
New CEPI-funded project will partner with Austria’s GENSPEED Biotech to repurpose its GENSPEED R2 device to create a fast, fully automated quality control test for detecting residual HEK293 host cell proteins, a critical step in ensuring vaccine safety and consistency.
As one of CEPI’s longest-standing and largest funders, Germany’s renewed commitment recognises that global cooperation, scientific excellence and solidarity are our best defences against future health crises.
October 12, 2025 at 2:50 PM
As one of CEPI’s longest-standing and largest funders, Germany’s renewed commitment recognises that global cooperation, scientific excellence and solidarity are our best defences against future health crises.
📢 Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI.
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
October 12, 2025 at 2:50 PM
📢 Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI.
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all.
cepi.net/bmftr-boosts...
Deutschland ist Gründungsmitglied und einer der größten Geldgeber von CEPI. Mit seiner erneuten Unterstützung wird Deutschland dazu beitragen, die Mission von CEPI voranzutreiben, viele der gefährlichsten Epidemien und Pandemien weltweit zum Wohle aller zu bekämpfen.
October 12, 2025 at 2:45 PM
Deutschland ist Gründungsmitglied und einer der größten Geldgeber von CEPI. Mit seiner erneuten Unterstützung wird Deutschland dazu beitragen, die Mission von CEPI voranzutreiben, viele der gefährlichsten Epidemien und Pandemien weltweit zum Wohle aller zu bekämpfen.
📢 Die Bundesrepublik Deutschland hat ihre weltweite Vorreiterrolle im Gesundheitsbereich mit einer erneuten Zusage in Höhe von 100 Millionen Euro für CEPI bekräftigt.
October 12, 2025 at 2:45 PM
📢 Die Bundesrepublik Deutschland hat ihre weltweite Vorreiterrolle im Gesundheitsbereich mit einer erneuten Zusage in Höhe von 100 Millionen Euro für CEPI bekräftigt.
How can #AI accelerate vaccine development and strengthen pandemic preparedness?
This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.
This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.
October 3, 2025 at 11:06 AM
How can #AI accelerate vaccine development and strengthen pandemic preparedness?
This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.
This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.
CEPI is partnering with UKHSA & Fondation Mérieux through two new framework agreements aimed at strengthening biosecurity capacities in the DRC, supporting CEPI’s existing R&D partners in the region.
📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.
📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.
September 26, 2025 at 1:52 PM
CEPI is partnering with UKHSA & Fondation Mérieux through two new framework agreements aimed at strengthening biosecurity capacities in the DRC, supporting CEPI’s existing R&D partners in the region.
📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.
📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.
📺💡A new BBC Horizon documentary, ‘Disease X: Hunting the next pandemic’ delves into the potential deadly threat of a future unknown disease that could spread globally – and the possible culprit viral families it could come from, such as a virus related to the deadly Nipah or influenza strains (1/3)
September 23, 2025 at 10:33 AM
📺💡A new BBC Horizon documentary, ‘Disease X: Hunting the next pandemic’ delves into the potential deadly threat of a future unknown disease that could spread globally – and the possible culprit viral families it could come from, such as a virus related to the deadly Nipah or influenza strains (1/3)
📣 Four global health and science experts, widely recognised for their contributions in tackling deadly infectious disease threats, have been appointed to key governance positions at CEPI.
▶️ cepi.net/top-health-a...
▶️ cepi.net/top-health-a...
September 16, 2025 at 10:24 AM
📣 Four global health and science experts, widely recognised for their contributions in tackling deadly infectious disease threats, have been appointed to key governance positions at CEPI.
▶️ cepi.net/top-health-a...
▶️ cepi.net/top-health-a...
Did you know the next pandemic is likely to emerge from one of 25 or so viral families?
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
September 12, 2025 at 1:09 PM
Did you know the next pandemic is likely to emerge from one of 25 or so viral families?
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
📣We're providing up to $10.4 million to work with international partners and gather real-world insights into the use of the Lc16m8 vaccine in protecting against mpox in the DRC.
The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...
The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...
September 11, 2025 at 10:51 AM
📣We're providing up to $10.4 million to work with international partners and gather real-world insights into the use of the Lc16m8 vaccine in protecting against mpox in the DRC.
The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...
The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...
📣Attending the ECOWAS Lassa Fever International Conference in Cote d’Ivoire next month?
Join us for our ‘Regional readiness for Lassa fever vaccines: Development to Access' session on Tuesday 9 September 8.30-10.00 AM GMT.
Join us for our ‘Regional readiness for Lassa fever vaccines: Development to Access' session on Tuesday 9 September 8.30-10.00 AM GMT.
August 26, 2025 at 3:55 PM
📣Attending the ECOWAS Lassa Fever International Conference in Cote d’Ivoire next month?
Join us for our ‘Regional readiness for Lassa fever vaccines: Development to Access' session on Tuesday 9 September 8.30-10.00 AM GMT.
Join us for our ‘Regional readiness for Lassa fever vaccines: Development to Access' session on Tuesday 9 September 8.30-10.00 AM GMT.
DYK: Mosquitoes cause more human deaths than any other creature each year 🦟 #WorldMosquitoDay
Vectors of viruses like dengue, Zika, chikungunya and malaria, mosquitoes contribute to around 700,000 deaths each year, according to @who.int.
And their geographic reach is spreading...
Vectors of viruses like dengue, Zika, chikungunya and malaria, mosquitoes contribute to around 700,000 deaths each year, according to @who.int.
And their geographic reach is spreading...
August 20, 2025 at 11:11 AM
DYK: Mosquitoes cause more human deaths than any other creature each year 🦟 #WorldMosquitoDay
Vectors of viruses like dengue, Zika, chikungunya and malaria, mosquitoes contribute to around 700,000 deaths each year, according to @who.int.
And their geographic reach is spreading...
Vectors of viruses like dengue, Zika, chikungunya and malaria, mosquitoes contribute to around 700,000 deaths each year, according to @who.int.
And their geographic reach is spreading...
New vaccine milestone reached for Rift Valley fever 💉
On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)
On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)
August 15, 2025 at 9:58 AM
New vaccine milestone reached for Rift Valley fever 💉
On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)
On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)
💡Enable 1.5 is a pioneering CEPI study working to advance our understanding of Lassa virus and help inform Lassa fever vaccine development.
Read the study protocol, now in @bmj.com Public Health: bmjpublichealth.bmj.com/content/3/2/...
📸 Enable 1.5 participants in Nigeria | Nigeria CDC.
Read the study protocol, now in @bmj.com Public Health: bmjpublichealth.bmj.com/content/3/2/...
📸 Enable 1.5 participants in Nigeria | Nigeria CDC.
August 8, 2025 at 11:29 AM
💡Enable 1.5 is a pioneering CEPI study working to advance our understanding of Lassa virus and help inform Lassa fever vaccine development.
Read the study protocol, now in @bmj.com Public Health: bmjpublichealth.bmj.com/content/3/2/...
📸 Enable 1.5 participants in Nigeria | Nigeria CDC.
Read the study protocol, now in @bmj.com Public Health: bmjpublichealth.bmj.com/content/3/2/...
📸 Enable 1.5 participants in Nigeria | Nigeria CDC.
#Chikungunya is a mosquito-borne disease belonging to the togavirus viral family🦠
It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟
It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟
August 7, 2025 at 11:35 AM
#Chikungunya is a mosquito-borne disease belonging to the togavirus viral family🦠
It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟
It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟
@ippsecretariat.org's 100 Days Mission Scorecard helps track progress across these countermeasures.
Worryingly it finds that of the 25 viral families likely to spawn the next pandemic, most do not have a complete set of diagnostics, therapeutics or vaccines to defend against them.
Worryingly it finds that of the 25 viral families likely to spawn the next pandemic, most do not have a complete set of diagnostics, therapeutics or vaccines to defend against them.
July 30, 2025 at 10:19 AM
@ippsecretariat.org's 100 Days Mission Scorecard helps track progress across these countermeasures.
Worryingly it finds that of the 25 viral families likely to spawn the next pandemic, most do not have a complete set of diagnostics, therapeutics or vaccines to defend against them.
Worryingly it finds that of the 25 viral families likely to spawn the next pandemic, most do not have a complete set of diagnostics, therapeutics or vaccines to defend against them.
📣 CEPI and the Indian Council of Medical Research have signed a new MoU to strengthen collaboration on developing accessible, affordable vaccines against emerging and re-emerging infectious diseases.
July 25, 2025 at 9:48 AM
📣 CEPI and the Indian Council of Medical Research have signed a new MoU to strengthen collaboration on developing accessible, affordable vaccines against emerging and re-emerging infectious diseases.
What do you know about #Nipah virus, one of the world's most lethal pathogens?
Learn more in the video below or on CEPI's website: cepi.net/nipah
Learn more in the video below or on CEPI's website: cepi.net/nipah
July 3, 2025 at 11:36 AM
What do you know about #Nipah virus, one of the world's most lethal pathogens?
Learn more in the video below or on CEPI's website: cepi.net/nipah
Learn more in the video below or on CEPI's website: cepi.net/nipah
DYK: By the time COVAX closed in late 2023, COVAX partners—CEPI, @gavi.org, @who.int and @unicef.org —helped deliver around 2 billion COVID-19 vaccine doses to 146 countries, saving an estimated 2.7 million lives in low- and middle-income countries.
July 2, 2025 at 12:12 PM
DYK: By the time COVAX closed in late 2023, COVAX partners—CEPI, @gavi.org, @who.int and @unicef.org —helped deliver around 2 billion COVID-19 vaccine doses to 146 countries, saving an estimated 2.7 million lives in low- and middle-income countries.
A CEPI-funded trial has launched in the DRC to assess an mpox vaccine in pregnant women, new mothers and infants under two💉🌍
The data could help "enable protection of these vulnerable populations" says CEPI's Mpox Disease Programme Lead, Kristine Rose: www.bavarian-nordic.com/investor/new...
The data could help "enable protection of these vulnerable populations" says CEPI's Mpox Disease Programme Lead, Kristine Rose: www.bavarian-nordic.com/investor/new...
July 1, 2025 at 12:39 PM
A CEPI-funded trial has launched in the DRC to assess an mpox vaccine in pregnant women, new mothers and infants under two💉🌍
The data could help "enable protection of these vulnerable populations" says CEPI's Mpox Disease Programme Lead, Kristine Rose: www.bavarian-nordic.com/investor/new...
The data could help "enable protection of these vulnerable populations" says CEPI's Mpox Disease Programme Lead, Kristine Rose: www.bavarian-nordic.com/investor/new...
"Speeding up vaccine development to 100 days could better prepare the world for the next outbreak" writes our CEO @drrhatchett.bsky.social in today’s print copy of @theguardian.com as part of the #GlobalHealthResilience campaign.
shorturl.at/pHgFD
shorturl.at/pHgFD
June 30, 2025 at 11:20 AM
"Speeding up vaccine development to 100 days could better prepare the world for the next outbreak" writes our CEO @drrhatchett.bsky.social in today’s print copy of @theguardian.com as part of the #GlobalHealthResilience campaign.
shorturl.at/pHgFD
shorturl.at/pHgFD